Fig. 5.
![Fig. 5. Increase of trf-rec mRNA concentration upon Epo-treatment of K562 cells. K562 cells were treated for 24 hours with 50 μmol/L Fe(NO3 )3 (I), 100 μmol/L desferrioxamine (D), or the indicated concentrations of human recombinant Epo (Epo) or remained untreated (control [C]). The total RNA was then extracted and 10 μg was subjected to Northern blotting with a human trf-rec cDNA or a rat GAPDH probe. The results of one of three similar experiments are shown.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/89/2/10.1182_blood.v89.2.680/4/bl_0026f5.jpeg?Expires=1724254123&Signature=xnW4Or2v9QgvJhR~rho5BcUHNL3HX8tOvmOCsQdRo9gZoE9KkSKiaGB3fTVJwaDhhnZtlL3A2CvPp3ubA5sD-AyOVi~uNmdRDAxYDEVfHVbQ6MVs4IM0PUqHmhgaPMWZdtJSd2e~OvC4aod8AvtGQGiD00fzUgnZZlgQ3cgXHhyZG3MlaLrLNPcJH~jLpEmSAHUhQZ8m7tQFxJ8h2qbrEVjFQ1TMamHcgIwkuttytc6OoA5UFIOczwox-fozdmNVkWNciS7hsqJthXGMWHcfdoheH8KHypxfeAGIgTH5jbkC~BTduIJdfH2ByyLKtMQgk6me3YRNQlipChgan46y-g__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Increase of trf-rec mRNA concentration upon Epo-treatment of K562 cells. K562 cells were treated for 24 hours with 50 μmol/L Fe(NO3 )3 (I), 100 μmol/L desferrioxamine (D), or the indicated concentrations of human recombinant Epo (Epo) or remained untreated (control [C]). The total RNA was then extracted and 10 μg was subjected to Northern blotting with a human trf-rec cDNA or a rat GAPDH probe. The results of one of three similar experiments are shown.
